Date | Title | Description | |
---|---|---|---|
10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
10 May 2023 | Announcement of General Shareholders’ Meeting | ROVI releases the information related to its General Shareholders Meeting | Download |
10 Apr 2023 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the first quarter of 2023 | Download |
21 Feb 2023 | Annual Corporate Governance Report | ROVI releases the 2022 Annual Corporate Governance Report | Download |
21 Feb 2023 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors | Download |
16 Feb 2023 | On business and financial situation | The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
09 Jun 2015 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
03 Jun 2015 | Acuerdos estratégicos con terceros | Download | |
06 May 2015 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
29 Apr 2015 | Información sobre resultados (2) | Download | |
29 Apr 2015 | Información sobre resultados | Download |